Drugs / MQX-503
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00378521 | Jul 2006 | Raynaud disease | MediQuest Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MQX-503 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00378521 ↗ |
| Route | Topical | “a topical gel formulation” NCT00378521 ↗ |